Oncology Medical News about stem cell transplant

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Toxicity of a second autologous peripheral blood stem cell transplant in patients with relapsed or recurrent multiple myeloma
Leukemia and Lymphoma, 09/18/09

Burzynski JA et al. – Toxicity associated with a second autologous peripheral blood stem cell transplant (APBSCT) in patients who relapse following initial APBSCT for multiple myeloma (MM) has not been well described. Delayed platelet engraftment and an 8% treatment–related mortality were observed following the second APBSCT.

<< Previous
In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms...

Next >>
Irradiation Alters Selection for Oncogenic Mutations in...